Drug Profile
Research programme: therapeutic antibodies - Lexicon Pharmaceuticals/Organon
Alternative Names: LG 106Latest Information Update: 24 Mar 2010
Price :
$50
*
At a glance
- Originator Lexicon Genetics; Organon
- Class Antibodies; Proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Cancer; Inflammation
Most Recent Events
- 27 Nov 2008 This programme is still in active development
- 19 Nov 2007 Organon has been acquired and merged into Schering-Plough
- 15 May 2007 This programme is still in active development